Australia Medical Devices Reimbursement Market Size & Outlook
The medical devices reimbursement market in Australia is expected to reach a projected revenue of US$ 20,647.6 million by 2033. A compound annual growth rate of 8.1% is expected of Australia medical devices reimbursement market from 2026 to 2033.
Australia medical devices reimbursement market highlights
The Australia medical devices reimbursement market generated a revenue of USD 11,153.8 million in 2025 and is expected to reach USD 20,647.6 million by 2033.
The Australia market is expected to grow at a CAGR of 8.1% from 2026 to 2033.
In terms of segment, underpaid was the largest revenue generating claim in 2025.
Underpaid is the most lucrative claim segment registering the fastest growth during the forecast period.
Medical devices reimbursement market data book summary
Market revenue in 2025
USD 11,153.8 million
Market revenue in 2033
USD 20,647.6 million
Growth rate
8.1% (CAGR from 2026 to 2033)
Largest segment
Underpaid
Fastest growing segment
Underpaid
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Underpaid, Full Paid
Key market players worldwide
Aviva PLC, CVS Health Corp, BNP Paribas Act. Cat.A, Allianz SE, Humana Inc, The Cigna Group, UnitedHealth Group Inc, Nippon Life Insurance Company of Japan, WellCare Health Plans, Elevance Health
Other key industry trends
In terms of revenue, Australia accounted for 1.3% of the global medical devices reimbursement market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China medical devices reimbursement market is projected to lead the regional market in terms of revenue in 2033.
Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,158.9 million by 2033.
Australia Medical Devices Reimbursement Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Medical Devices Reimbursement Market Outlook will help companies and investors design strategic landscapes.
Underpaid was the largest segment with a revenue share of 86.95% in 2025.
Horizon Databook has segmented the Australia medical devices reimbursement market based on underpaid, full paid covering the revenue growth of each sub-segment from 2021 to 2033.
Australia Medical Devices Reimbursement Market Claim Outlook (Revenue, USD Million , 2021-2033)
Underpaid
Full Paid
Australia Medical Devices Reimbursement Market Payer Outlook (Revenue, USD Million , 2021-2033)
Public payers
Private payers
Australia Medical Devices Reimbursement Market Service Provider Outlook (Revenue, USD Million , 2021-2033)
Physician Office
Hospitals
Diagnostic Laboratories
Others
Reasons to subscribe to Medical Devices Reimbursement Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Medical Devices Reimbursement Market Outlook databook
Our clientele includes a mix of Medical Devices Reimbursement Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Medical Devices Reimbursement Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Medical Devices Reimbursement Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Medical Devices Reimbursement Market, 2021-2033 (US$M)